TNF Receptor Superfamily Member 6 / CD95 / TNFRSF6 (FAS) Antibody (PE)

Este producto es parte de FAS - Fas cell surface death receptor
Product Graph
429€ (100 tests)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
TNF Receptor Superfamily Member 6 / CD95 / TNFRSF6 (FAS) Antibody (PE)
category
Primary Antibodies
provider
Abbexa
reference
abx139050
tested applications
FCM

Description

CD95 Antibody is a Mouse Monoclonal against CD95.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
TNF Receptor Superfamily Member 6 / CD95 / TNFRSF6 (FAS)
Host
Mouse
Reactivity
Human
Recommended Dilution
FCM: 20 µl/100 µl of whole blood or 106 cells. Validated in IHC-P. Optimal dilutions/concentrations should be determined by the end user.The content of a vial (2 ml) is sufficient for 100 tests.
Clonality
Monoclonal
Conjugation
PE
Isotype
IgG1
Clone ID
E504
Size 1
100 tests
Tested Applications
FCM
Buffer
Stabilizing PBS solution containing 15 mM sodium azide.
Availability
Shipped within 5-12 working days.
Storage
Store in the dark at 2-8°C. Avoid exposure to light. Do not freeze.
Dry Ice
No
UniProt ID
P25445
Gene ID
355
Alias
APT1,CD95,FAS1,APO-1,FASTM,ALPS1A,TNFRSF6,Apo-1 antigen,Apoptosis-mediating surface antigen FAS,FASLG receptor
Background
Antibody anti-FAS
Status
RUO

Descripción

Tumor necrosis factor receptor superfamily member 6 (FAS), also known as CD95, is a cell surface receptor involved in the regulation of apoptosis through the extrinsic pathway FAS belongs to the TNF receptor family and triggers apoptosis upon binding with its ligand, FASL This interaction activates the caspase cascade, leading to programmed cell death FAS-mediated apoptosis plays a critical role in immune system regulation, particularly in eliminating autoreactive T-cells during immune tolerance and in regulating the survival of activated immune cells In addition to immune regulation, FAS signaling is involved in tumor progression, where altered expression of FAS or its ligand can either promote or inhibit cancer cell survival In many cancers, FAS expression is dysregulated, contributing to resistance to apoptosis and enabling tumor cell evasion from immune surveillance FAS has also been implicated in autoimmune diseases, where inappropriate activation or inhibition of FAS signaling can lead to tissue damage and chronic inflammation

Related Products

EH0126

Human FAS(Tumor necrosisfactor receptor superfamily member 6) ELISA Kit

Ver Producto
EM0076

Mouse FAS(Factor Related Apoptosis) ELISA Kit

Ver Producto
EP0204

Porcine FAS/CD95(TNF receptor superfamily, member 6) ELISA Kit

Ver Producto